Cryosa Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $5.99M

  • Investors
  • 6

Cryosa General Information

Description

Developer of a medical device designed to assist patients with sleep-disordered breathing. The company's device offers treatments that are focused on treating obstructive sleep apnea, enabling people suffering from moderate to severe sleep apnea disorder.

Contact Information

Website
www.cryosa.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1265 Grey Fox Road
  • Suite 5
  • Arden Hills, MN 55112
  • United States
+1 (210)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 1265 Grey Fox Road
  • Suite 5
  • Arden Hills, MN 55112
  • United States
+1 (210)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cryosa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B1) 15-Jul-2025 $5.99M Completed Clinical Trials - Phase 1
3. Early Stage VC (Series B) 23-Sep-2021 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A2) 26-Jun-2020 $8.25M $12.8M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 20-Apr-2018 $4.5M $4.5M Completed Startup
To view Cryosa’s complete valuation and funding history, request access »

Cryosa Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1
Series B2
Series A3
Series A2 5,692,953 $0.000100 $0.12 $1.45 $1.45 1x $1.45 10.02%
Series A1 5,085,283 $0.000100 $0.07 $0.88 $0.88 1x $0.88 8.95%
To view Cryosa’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cryosa Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical device designed to assist patients with sleep-disordered breathing. The company's device offers t
Therapeutic Devices
Arden Hills, MN
13 As of 2026

Zhubei, Taiwan
 

Mont-Saint-Guibert, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cryosa Competitors (4)

One of Cryosa’s 4 competitors is Somnics, a Venture Capital-Backed company based in Zhubei, Taiwan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Somnics Venture Capital-Backed Zhubei, Taiwan
Nyxoah Formerly VC-backed Mont-Saint-Guibert, Belgium
ResMed Corporation San Diego, CA
Inspire Medical Systems Formerly VC-backed Golden Valley, MN
To view Cryosa’s complete competitors history, request access »

Cryosa Patents

Cryosa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025255111-A1 Soft palate cryoprobes for treatment of obstructive sleep apnea, and associated systems, devices and methods Pending 03-Jun-2024
WO-2025255114-A1 Tongue cryoprobes for treatment of obstructive sleep apnea, and associated systems, devices and methods Pending 03-Jun-2024
AU-2024365454-A1 Methods and systems for inducing apoptosis of adipose cells Pending 27-Oct-2023
US-20250134915-A1 Methods and systems for inducing apoptosis of adipose cells Pending 27-Oct-2023
US-20250135004-A1 Methods and systems for inducing apoptosis of adipose cells Pending 27-Oct-2023 A61K31/517
To view Cryosa’s complete patent history, request access »

Cryosa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cryosa Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gravity Fund Venture Capital Minority
Brightstone Venture Capital Venture Capital Minority
Gershon Capital Venture Capital Minority
Hoya Corporation Minority
Solas BioVentures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Cryosa FAQs

  • When was Cryosa founded?

    Cryosa was founded in 2018.

  • Where is Cryosa headquartered?

    Cryosa is headquartered in Arden Hills, MN.

  • What is the size of Cryosa?

    Cryosa has 13 total employees.

  • What industry is Cryosa in?

    Cryosa’s primary industry is Therapeutic Devices.

  • Is Cryosa a private or public company?

    Cryosa is a Private company.

  • What is the current valuation of Cryosa?

    The current valuation of Cryosa is .

  • What is Cryosa’s current revenue?

    The current revenue for Cryosa is .

  • How much funding has Cryosa raised over time?

    Cryosa has raised $40.2M.

  • Who are Cryosa’s investors?

    Gravity Fund, Brightstone Venture Capital, Gershon Capital, Hoya, and Solas BioVentures are 5 of 6 investors who have invested in Cryosa.

  • Who are Cryosa’s competitors?

    Somnics, Nyxoah, ResMed, and Inspire Medical Systems are competitors of Cryosa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process